RxDoctor Payments Data

Gordon Mathes

Urology · Rocky Mount, NCNPI 1871556977

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.6% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Astellas Pharma US Inc at 38.0% of the total. Reporting peaked in 2019 at $878 and has fallen 94.1% since, to $52 in 2022. That places this record below the midpoint for urology clinicians in NC, where the typical reported total is $2,562.

$1,867in general payments, 2019–2025

Across 114 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$710
  • Dendreon Pharmaceuticals LLC$409
  • AbbVie$137
  • Travere Therapeutics, Inc.$118
  • Ferring Pharmaceuticals Inc.$99
  • Pfizer$59
  • plus $336 from 12 others

What the payments were for

  • Food & beverage$1,76795%
  • Education$1005%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,867 in reported general payments places this provider in the 40th percentile of 434 urology providers in North Carolina.

See all urology providers in North Carolina →

Other urology in Rocky Mount

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →